Brief: Knight Therapeutics Reports Third Quarter 2020 Results
13/11/2020 12:33
Nov 13 (Reuters) - Knight Therapeutics Inc GUD.TO :
* KNIGHT THERAPEUTICS REPORTS THIRD QUARTER 2020 RESULTS
* KNIGHT THERAPEUTICS INC - QTRLY REVENUES C$45.2 MILLION
VERSUS
C$4 MILLION
* KNIGHT THERAPEUTICS INC - QTRLY BASIC EARNINGS PER SHARE
C$0.14
Source text for Eikon: ID:nGNXbw7SHt
Further company coverage: GUD.TO
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Knight Therapeutics
See all newsBrief: Knight Therapeutics Announces Regulatory Approval Of Niktimvo In Brazil
Brief: Knight Therapeutics - Launches Tavalisse In Brazil For Chronic Immune Thrombocytopenia
Brief: Knight Therapeutics Enters Into Exclusive Distribution Agreement With Kyowa Kirin International For Poteligeo® (Mogamulizumab)
Brief: Knight Therapeutics Announces Regulatory Approval Of Tavalisse® In Colombia
Brief: Knight Therapeutics Announces Supplemental Regulatory Submission For Minjuvi In Brazil